Komori
Atomix (4625) · RiskDropped

Business Continuity and Performance Risks from the Spread of a Novel Infectious Disease

First written in FY2020. 6 of 17 entries say "Mitigated", first in FY2023-Q2. Latest entry: FY2025.

17entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2020 – FY2021-Q3MitigatedFY2023-Q2 – FY20242020: 320202021: 420212022: 420222023: 320232024: 220242025: 12025
Same theme, other companies
Impact of COVID-19 on Business Continuity and Sales ActivitiesA theme 130 companies write about · 129 as a headwind · 0 as a tailwind

Atomix moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.

The whole theme swung hardest in 2020: 88 of 125 companies on the "Worse" side.

26 other companies' latest entry also says "Dropped".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 130 companies compared. The sentences above are computed from all 130.
Full recordFilings, disclosures and news, newest first
  1. FY2025DroppedAnnual report

    「During the consolidated fiscal year under review, Japan’s economy was gradually recovering as economic activity normalized and personal consumption and capital investment remained solid, but」

    The descriptions concerning the spread of COVID-19 and restrictions on activity that had continued through the previous fiscal year could not be found among the operating environment and key risks for the fiscal year under review.
  2. FY2024MitigatedAnnual report

    「As the normalization of social and economic activity advances further following the reclassification of COVID-19 as a “Category 5 infectious disease,”」

    The Company states that the normalization of social and economic activity has advanced further following the reclassification of COVID-19 as a Category 5 infectious disease.
  3. FY2024-Q3MitigatedAnnual report

    「As the normalization of social and economic activity advances further following the reclassification of COVID-19 as a “Category 5 infectious disease,”」

    The Company states that the normalization of social and economic activity has advanced further following the reclassification of COVID-19 as a Category 5 infectious disease, further reducing the risk of activity restrictions caused by the infectious disease.
  4. FY2024-Q2MitigatedAnnual report

    「Social and economic activity has been recovering as COVID-19 was reclassified as a “Category 5 infectious disease,” but」

    The Company states that COVID-19 was reclassified as a “Category 5 infectious disease” and that social and economic activity is recovering.
  5. FY2024-Q1MitigatedAnnual report

    「While social and economic activity is moving toward normalization following the reclassification of COVID-19,」

    The Company states that social and economic activity is moving toward normalization following the reclassification of COVID-19, representing an easing from the previous restrictions on activity.
  6. FY2023-Q3MitigatedAnnual report

    「The economy has continued to recover gradually as restrictions on activity related to COVID-19 have been eased, but」

    The Company continues to describe the easing of restrictions on activity related to COVID-19 and the economy’s gradual recovery.
  7. FY2023-Q2MitigatedAnnual report

    「During the six-month consolidated period under review, Japan’s economy was gradually recovering as restrictions on activity caused by COVID-19 were eased, although」

    The Company states that restrictions on activity related to COVID-19 were eased and the economy was gradually recovering, representing a partial easing from the restrictions in place through the previous fiscal year.
  8. FY2023-Q1RestatedAnnual report

    「During the first quarter of the consolidated fiscal year under review, Japan’s economy showed signs of recovery as a result of infection-control measures and policy effects, although the impact of COVID-19 was prolonged,」

    The Company refers both to the prolonged impact of COVID-19 and to signs of recovery resulting from infection-control measures and policy effects.
  9. FY2022RestatedAnnual report

    「During the consolidated fiscal year under review, Japan’s economy continued to experience restrictions and stagnation in economic activity as declarations of a state of emergency and priority preventive measures were repeatedly requested due to the prolonged impact of COVID-19, but signs of recovery in economic activity emerged as a result of vaccinations and other measures.」

    The Company continues to describe the prolonged infectious disease and restrictions and stagnation in economic activity, while also referring to signs of recovery resulting from vaccinations and other measures.
  10. FY2022-Q3WorsenedAnnual report

    「Rapid renewed spread of the Omicron variant from the end of the year」

    The Company states that the rapid renewed spread of the Omicron variant began at the end of the year.
  11. FY2022-Q2RestatedAnnual report

    「As the renewed spread of COVID-19 led to the reissuance of a state of emergency, social and economic activity continued to be restricted,」

    The difficult business and operating environment caused by the renewed spread of infections and the reissuance of a state of emergency continues.
  12. FY2022-Q1WorsenedAnnual report

    「During the cumulative first quarter of the current consolidated fiscal period, social and economic activity remained difficult, including the reissuance of the state of emergency amid the resurgence of COVID-19 infections, and the outlook remained uncertain.」

    The Company describes a renewed spread of infections and the reissuance of a state of emergency, indicating that the difficult business and operating environment caused by COVID-19 continues.
  13. FY2021RestatedAnnual report

    「The global spread of COVID-19 continues, making it difficult to predict when the pandemic will end, but」

    The Company states that the global spread of the infectious disease and uncertainty over when it will end continue.
  14. FY2021-Q3WorsenedAnnual report

    「The trend toward a renewed spread of infections through the end of the year strengthened, and the timing of the end of the pandemic remained unforeseeable, making the economic outlook increasingly uncertain.」

    The Company states that, in addition to the continuing impact of COVID-19, the trend toward a renewed spread of infections strengthened through the end of the year and the timing of the end of the pandemic remained unforeseeable.
  15. FY2021-Q2MaterialisedAnnual report

    「During the six-month consolidated period under review, Japan’s economy was in an extremely difficult situation as the spread of COVID-19 significantly restricted social and economic activity. Although signs of recovery were seen in some industries as a result of various government measures, the outlook remained uncertain because the timing of the end of the COVID-19 pandemic could not be predicted.」

    The significant restrictions on social and economic activity caused by COVID-19 and the uncertain outlook continued during the second quarter.
  16. FY2021-Q1MaterialisedAnnual report

    「During the cumulative first quarter of the current consolidated fiscal period, the Japanese economy deteriorated sharply as the spread of COVID-19 severely constrained private consumption and corporate activity. After the state of emergency was lifted, expectations rose for a recovery in economic activity through various policies, but the outlook remained uncertain because the timing of the end of the COVID-19 pandemic could not be foreseen.」

    Restrictions on personal consumption and corporate activity and the deterioration of the economic environment caused by the spread of COVID-19 continued during the first quarter.
  17. FY2020MaterialisedAnnual report

    「In response to the spread of novel infectious diseases and other infections, the Group is collecting accurate information and promptly establishing appropriate internal systems for infection prevention and containment. However, if an infectious disease spreads, the Group’s operating results, financial condition and other matters could be affected, including through a temporary suspension of operations.」

    The global spread of COVID-19 and restrictions on economic activity actually occurred, and the impact on year-end sales was also described.
Moved together

"Market Price Volatility Risk on Investment Securities" moved the same way as this thread, in the same document, in 8 of its 17 moves.

866654★123456
  1. ★This thread
  2. 1Market Price Volatility Risk on Investment Securities8×
  3. 2Expansion of the Infrastructure Repair and Waterproofing Markets6×
  4. 3Addressing higher costs through price revisions for some products6×
  5. 4Asset Retirement Obligations Related to Asbestos and Soil Contamination6×
  6. 5Dependence on Trends in Capital Investment, Personal Consumption and Public Works5×
  7. 6Expanding Sales of Environmentally Friendly Products in the Road, Flooring and Waterproofing Markets4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Atomix's next results are scheduled for 2026-11-12. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.